Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Health

Offered Not-For-Profit Price For COVID Vax; To Supply Through Govt Contracts In India: Pfizer

'For India, Pfizer has offered a not-for-profit price for its vaccine for the government immunization program', it added without revealing the price.

Read More

VAV Lifesciences To Supply Key COVID Vaccine Ingredient To Pfizer, Moderna

The US firm will use the lipids made by VAV to produce gene-based lipid nanoparticles on behalf of the brand owners -- Pfizer-BioNTech and Moderna.

Read More

Reliance Increases Supply Of Oxygen To Over 700 Tonnes A Day To COVID-Hit States

Medical-grade oxygen is not a product that was produced at the Jamnagar refineries, which convert crude oil into products such as diesel, petrol and jet fuel.

Read More

Jubilant Pharmova Arm Completes Studies Using Novel Oral Formulation Of Remdesivir

Shares of Jubilant Pharmova were trading at Rs 775.30 per scrip on BSE, up 7.07 per cent from its previous close.

Read More

Sun Pharma, Alembic Recall Products In The US Market

Princeton (New Jersey) based Sun Pharmaceutical Industries Inc is also recalling 2,520 bottles of diabetes drug, Metformin HCl Extended-Release tablets, in the US market.

Read More

Indian Pharma Exports Grow At 18 Percent To 24.44 Bn In FY 21

Growth rate seems relatively big as the exports of March 2020 was crunched due to lockdown across the world and supply chain disruption, he was quoted as saying.

Read More

Zydus Cadila Gets USFDA Nod For Cancer And High Blood Pressure Treatment Drug

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 140 mg, Cadila Healthcare said in a regulatory filing.

Read More

Growth In The Healthcare And Technology Sector

Emerging healthcare segments like diagnostic chains, medical device manufacturers, and hospital chains are increasingly attracting investments from various venture capitalists.

Read More

FDA OKs First New ADHD Drug In Over A Decade For Children

The Food and Drug Administration late Friday OK''d Qelbree (KELL''-bree) for treating attention deficit hyperactivity disorder in children ages 6 to 17. It comes as a capsule that''s taken daily.

Read More

Unpredictable How Protective Vaccines Will Be Against New Covid Strains But Till Date Safe Against Outbreak: AIIMS Professor Neeraj Nischal

The enigma of incredibly complex Covid19 is still perplexing the science of medicine with severe mutations of SARS-CoV2 virus. This surge was expected as seen during the last major Influenza pandemic which happened a century ago. What are the new signs and symptoms? Will the current vaccines be able to fight the new strain? And what you must do to survive the deadly second wave which is causing more fatality ever? On such issues, India's leading expert, Dr Neeraj Nischal, Professor of Medicine at All India Institute of Medical Science (AIIMS), Delhi speaks with BW Businessworld’s Manish Kumar Jha. AIIMS professor sights that owing to the varied presentation of this disease, it wouldn't be incorrect to say that "any symptom could be a symptom of Covid-19". So don't let your guard off.

Read More

Bring 2 Lakh Indian Seafarers Under Ambit Of 'Priority Workers' For Vaccination: Maritime Bodies

The Maritime Association of Shipowners Shipmanagers and Agents (MASSA) Chairman Mahendra Bhasin said the current population of Indian seafarers is pegged at 2.5 lakh and this maritime workforces is working aboard thousands of ships worldwide.

Read More

GSK Pharma Board Approves Sale Of Vemgal Plant To Hetero Labs

Shares of GlaxoSmithKline Pharmaceuticals were trading at Rs 1,430.35 per scrip on BSE, up 0.38 per cent over previous close.

Read More

Covovax Trials Begin In India, Hope To Launch It By Sept 2021: Adar Poonawalla

American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.

Read More

Natco Pharma Board Okays Acquiring 1% In Canadian Arm

Stocks of Natco Pharma were trading 0.74 per cent lower at Rs 810.85 apiece on BSE.

Read More

Roche Buys GenMark For $1.8 Million To Challenge Test Rivals

The market for such tests in 2019 was $800 million annually, Roche diagnostics head Thomas Schinecker said, citing industry figures, adding it should grow by 20% annually to top $2 billion by 2024.

Read More